Prevalence of Treatment for Depression Among US Adults Who Screen Positive for Depression, 2007-2016

被引：19

作者：

Rhee, Taeho Greg ^{[1
,2
,3
]}

Wilkinson, Samuel T. ^{[2
]}

Steffens, David C. ^{[4
]}

Rosenheck, Robert A. ^{[2
,3
]}

Olfson, Mark ^{[5
]}

机构：

[1] Univ Connecticut, Sch Med, Dept Publ Hlth Sci, 263 Farmington Ave, Farmington, CT 06030 USA

[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA

[3] Vet Affairs Connecticut Healthcare Syst, New England Mental Illness Res Educ & Clin Ctr, West Haven, CT USA

[4] Univ Connecticut, Sch Med, Dept Psychiat, Farmington, CT 06032 USA

[5] Columbia Univ, Dept Psychiat, Vagelos Coll Phys & Surg, New York, NY USA

来源：

JAMA PSYCHIATRY | 2020年 / 77卷 / 11期

关键词：

D O I：

10.1001/jamapsychiatry.2020.1818

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This cohort study uses data from the National Health and Nutrition Examination Survey to examine changes in the prevalence of mental health treatment among US adults who screened positive for depression between 2007 and 2016.

引用

页码：1193 / 1195

页数：3

共 6 条

[1]

*CDCP, NAT HLTH NUTR EX SUR

[2] The PHQ-9 - Validity of a brief depression severity measure [J].

Kroenke, K ;

Spitzer, RL ;

Williams, JBW .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (09) :606-613

[3] The Relevance of the Affordable Care Act for Improving Mental Health Care [J].

Mechanic, David ;

Olfson, Mark .

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 12, 2016, 12 :515-542

[4] Treatment of Adult Depression in the United States [J].

Olfson, Mark ;

Blanco, Carlos ;

Marcus, Steven C. .

JAMA INTERNAL MEDICINE, 2016, 176 (10) :1482-1491

[5] Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders [J].

Rhee, Taeho Greg ;

Rosenheck, Robert A. .

JOURNAL OF AFFECTIVE DISORDERS, 2019, 252 :450-457

[6]

WHO, 2020, DEPRESSION

← 1 →